SCYNEXIS, Inc. Investing Cash Flow
SCYNEXIS, Inc. (SCYX) reported Investing Cash Flow of -$25.28 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-10
- SCYNEXIS, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$24.76M, a 319.62% decline year-over-year.
- SCYNEXIS, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$525.00K, a 104.22% decline year-over-year.
- SCYNEXIS, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$11.82M.
- SCYNEXIS, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $12.42M, a 539.72% increase year-over-year.
- SCYNEXIS, Inc. net cash provided by (used in) investing activities for fiscal 2025 was $24.31M, a 295.22% increase from fiscal 2024.
- SCYNEXIS, Inc. net cash provided by (used in) investing activities for fiscal 2024 was $6.15M.
- SCYNEXIS, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$34.88M.
- SCYNEXIS, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$27.39M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$24.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$25.28M 10-Q · filed 2026-08-10 | -$37.11M derived: sum of 3 quarters · filed 2026-08-10 | -$24.69M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$525.00K 10-Q · filed 2026-05-11 | -$12.35M derived: sum of 2 quarters · filed 2026-05-11 | $68.00K derived: sum of 3 quarters · filed 2026-05-11 | $11.34M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$11.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $593.00K derived: sum of 2 quarters · filed 2026-03-04 | $11.87M derived: sum of 3 quarters · filed 2026-08-10 | $24.31M 10-K · filed 2026-03-04 |
| 2025-09-30 | $12.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $23.69M derived: sum of 2 quarters · filed 2026-08-10 | $36.13M 10-Q · filed 2025-11-05 | $33.51M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $11.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $23.71M 10-Q · filed 2026-08-10 | $21.10M derived: sum of 3 quarters · filed 2026-08-10 | $23.04M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $12.44M 10-Q · filed 2026-05-11 | $9.82M derived: sum of 2 quarters · filed 2026-05-11 | $11.76M derived: sum of 3 quarters · filed 2026-05-11 | $13.14M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$676.00K derived: sum of 2 quarters · filed 2026-03-04 | $696.00K derived: sum of 3 quarters · filed 2026-03-04 | $6.15M 10-K · filed 2026-03-04 |
| 2024-09-30 | $1.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.31M derived: sum of 2 quarters · filed 2025-11-05 | $8.77M 10-Q · filed 2025-11-05 | $6.62M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $6.83M 10-Q · filed 2025-08-13 | $4.67M derived: sum of 3 quarters · filed 2025-08-13 | -$21.67M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $5.45M 10-Q · filed 2025-05-15 | $3.30M derived: sum of 2 quarters · filed 2025-05-15 | -$23.04M derived: sum of 3 quarters · filed 2025-05-15 | -$29.42M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | -$28.49M derived: sum of 2 quarters · filed 2025-03-12 | -$34.88M derived: sum of 3 quarters · filed 2025-03-12 | -$34.88M 10-K · filed 2025-03-12 |
| 2023-09-30 | -$26.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$32.73M derived: sum of 2 quarters · filed 2024-11-06 | -$32.73M 10-Q · filed 2024-11-06 | -$32.73M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$6.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$6.38M 10-Q · filed 2024-08-08 | -$6.38M derived: sum of 3 quarters · filed 2024-08-08 | -$33.76M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | $0.00 derived: sum of 2 quarters · filed 2024-05-08 | -$27.38M derived: sum of 3 quarters · filed 2024-05-08 | -$27.38M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$27.38M derived: sum of 2 quarters · filed 2024-03-28 | -$27.38M derived: sum of 3 quarters · filed 2024-03-28 | -$27.39M 10-K · filed 2024-03-28 |
| 2022-09-30 | -$27.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$27.38M derived: sum of 2 quarters · filed 2023-11-13 | -$27.39M 10-Q · filed 2023-11-13 | -$27.97M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$9.00K 10-Q · filed 2023-08-14 | -$592.00K derived: sum of 3 quarters · filed 2023-08-14 | -$930.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$9.00K 10-Q · filed 2023-05-10 | -$592.00K derived: sum of 2 quarters · filed 2023-05-10 | -$930.00K derived: sum of 3 quarters · filed 2023-05-10 | -$981.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$583.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$921.00K derived: sum of 2 quarters · filed 2023-03-31 | -$972.00K derived: sum of 3 quarters · filed 2023-03-31 | -$1.17M 10-K · filed 2023-03-31 |
| 2021-09-30 | -$338.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$389.00K derived: sum of 2 quarters · filed 2022-11-09 | -$589.00K 10-Q · filed 2022-11-09 | -$589.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$251.00K 10-Q · filed 2022-08-15 | -$251.00K derived: sum of 3 quarters · filed 2022-08-15 | $3.32M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$200.00K 10-Q · filed 2022-05-12 | -$200.00K derived: sum of 2 quarters · filed 2022-05-12 | $3.37M derived: sum of 3 quarters · filed 2022-05-12 | $14.04M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $3.57M derived: sum of 2 quarters · filed 2022-03-29 | $14.24M derived: sum of 3 quarters · filed 2022-03-29 | $6.47M 10-K · filed 2022-03-29 |
| 2020-09-30 | $3.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $14.24M derived: sum of 2 quarters · filed 2021-11-10 | $6.47M 10-Q · filed 2021-11-10 | $16.52M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $10.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $2.90M 10-Q · filed 2021-08-16 | $12.95M derived: sum of 3 quarters · filed 2021-08-16 | $12.53M derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | -$7.76M 10-Q · filed 2021-05-17 | $2.28M derived: sum of 2 quarters · filed 2021-05-17 | $1.86M derived: sum of 3 quarters · filed 2021-05-17 | $11.88M derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $10.04M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $9.62M derived: sum of 2 quarters · filed 2021-03-29 | $19.64M derived: sum of 3 quarters · filed 2021-03-29 | $26.24M 10-K · filed 2021-03-29 |
| 2019-09-30 | -$421.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $9.60M derived: sum of 2 quarters · filed 2020-11-06 | $16.20M 10-Q · filed 2020-11-06 | $16.79M derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | $10.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $16.62M 10-Q · filed 2020-08-10 | $17.21M derived: sum of 3 quarters · filed 2020-08-10 | $32.15M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $6.60M 10-Q · filed 2020-05-11 | $7.19M derived: sum of 2 quarters · filed 2020-05-11 | $22.13M derived: sum of 3 quarters · filed 2020-05-11 | $9.80M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $595.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $15.53M derived: sum of 2 quarters · filed 2020-03-11 | $3.20M derived: sum of 3 quarters · filed 2020-03-11 | -$803.00K 10-K · filed 2020-03-11 |
| 2018-09-30 | $14.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $2.61M derived: sum of 2 quarters · filed 2019-11-12 | -$1.40M 10-Q · filed 2019-11-12 | $5.17M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | -$12.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$16.34M 10-Q · filed 2019-08-07 | -$9.77M derived: sum of 3 quarters · filed 2019-08-07 | -$6.83M derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | -$4.00M 10-Q · filed 2019-05-08 | $2.56M derived: sum of 2 quarters · filed 2019-05-08 | $5.50M derived: sum of 3 quarters · filed 2019-05-08 | -$1.46M derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | $6.56M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $9.51M derived: sum of 2 quarters · filed 2019-03-14 | $2.54M derived: sum of 3 quarters · filed 2019-03-14 | -$9.62M 10-K · filed 2019-03-14 |
| 2017-09-30 | $2.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$4.02M derived: sum of 2 quarters · filed 2018-11-13 | -$16.18M 10-Q · filed 2018-11-13 | -$10.56M derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | -$6.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$19.13M 10-Q · filed 2018-08-09 | -$13.50M derived: sum of 3 quarters · filed 2018-08-09 | -$29.11M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | -$12.16M 10-Q · filed 2018-05-08 | -$6.54M derived: sum of 2 quarters · filed 2018-05-08 | -$22.15M derived: sum of 3 quarters · filed 2018-05-08 | -$34.62M derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | $5.63M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | -$9.99M derived: sum of 2 quarters · filed 2018-03-13 | -$22.46M derived: sum of 3 quarters · filed 2018-03-13 | -$22.47M 10-K · filed 2018-03-13 |
| 2016-09-30 | -$15.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$28.08M derived: sum of 2 quarters · filed 2017-11-07 | -$28.10M 10-Q · filed 2017-11-07 | -$28.51M derived: sum of 4 quarters · filed 2017-11-07 |
| 2016-06-30 | -$12.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$12.49M 10-Q · filed 2017-08-08 | -$12.90M derived: sum of 3 quarters · filed 2017-08-08 | -$10.37M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | -$14.00K 10-Q · filed 2017-05-08 | -$430.00K derived: sum of 2 quarters · filed 2017-05-08 | $2.10M derived: sum of 3 quarters · filed 2017-05-08 | $1.74M derived: sum of 4 quarters · filed 2017-05-08 |
| 2015-12-31 | -$416.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $2.11M derived: sum of 2 quarters · filed 2017-03-13 | $1.76M derived: sum of 3 quarters · filed 2017-03-13 | $1.59M 10-K · filed 2017-03-13 |
| 2015-09-30 | $2.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $2.17M derived: sum of 2 quarters · filed 2016-11-07 | $2.00M 10-Q · filed 2016-11-07 | $1.93M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-06-30 | -$356.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$527.00K 10-Q · filed 2016-08-08 | -$599.00K derived: sum of 3 quarters · filed 2017-03-13 | |
| 2015-03-31 | -$171.00K 10-Q · filed 2016-05-09 | -$243.00K derived: sum of 2 quarters · filed 2017-03-13 | ||
| 2014-12-31 | -$72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | -$488.00K 10-K · filed 2017-03-13 | ||
| 2014-09-30 | -$416.00K 10-Q · filed 2015-11-13 | |||
| 2014-03-31 | -$74.00K 10-Q/A · filed 2014-07-11 | |||
| 2013-03-31 | $248.00K 10-Q/A · filed 2014-07-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |